Clinical Trial Detail

NCT ID NCT04375384
Title Study to Evaluate Effect of Cetuximab Given as Single Agent After Immunotherapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Wake Forest University Health Sciences
Indications

head and neck squamous cell carcinoma

Therapies

Cetuximab

Age Groups: senior adult

No variant requirements are available.